Curbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations

dc.contributor.authorShomuyiwa D.O.
dc.contributor.authorLucero-Prisno D.E.
dc.contributor.authorManirambona E.
dc.contributor.authorSuleman M.H.
dc.contributor.authorRayan R.A.
dc.contributor.authorHuang J.
dc.contributor.authorZaw T.N.
dc.contributor.authorBabatunde Y.
dc.contributor.authorDenkyira S.A.
dc.contributor.authorMusa S.S.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:44:07Z
dc.date.available2023-06-18T17:44:07Z
dc.date.issued2022-09-01
dc.description.abstractBackground: Antimicrobial self-medication and use have significantly increased in the COVID-19 era—increasing antibiotic consumption and resulting in a high prevalence of antimicrobial resistance in Africa (AMR). We conducted a narrative review to investigate challenges associated with curbing AMR in a post-COVID-19 setting in Africa, suggesting practical measures applicable for policy-informed implementation. Method: A narrative review was performed to pinpoint AMR challenges and actions on the African continent. A comprehensive search was conducted in the scientific databases that include PubMed, PubMed Central and Google Scholar using predetermined search terms. Results: The emergence of the COVID-19 outbreak has added to the challenges of tackling AMR on the continent, which has jeopardized AMR interventions' hard-won gains. Identified challenges have been Health systems disruption, Irrational Antimicrobial Use, Weak Antimicrobials Regulatory Ecosystem, Inefficient Population Infection Prevention, and Control Practices, Inadequate access to Health Services and data challenge on AMR surveillance. Conclusion: The COVID-19 pandemic fueled AMR in Africa. There is a need for AMR control post-COVID, such as measures for ongoing antimicrobial stewardship and good infection control practices. Further, curbing AMR requires rigorous regulatory enforcement and efficient AMR Surveillance. There should be a body to raise AMR awareness among the population. Research, Innovation and Technology could play an essential role supported by capacity building and global partnership.
dc.identifier.citationHealth Science Reports Vol.5 No.5 (2022)
dc.identifier.doi10.1002/hsr2.771
dc.identifier.eissn23988835
dc.identifier.scopus2-s2.0-85139045115
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85544
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleCurbing antimicrobial resistance in post-COVID Africa: Challenges, actions and recommendations
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85139045115&origin=inward
oaire.citation.issue5
oaire.citation.titleHealth Science Reports
oaire.citation.volume5
oairecerif.author.affiliationOxford University Hospitals NHS Foundation Trust
oairecerif.author.affiliationCentre for the AIDS Programme of Research in South Africa
oairecerif.author.affiliationChinese University of Hong Kong, Faculty of Medicine
oairecerif.author.affiliationUniversity of Rwanda
oairecerif.author.affiliationKwame Nkrumah University of Science and Technology
oairecerif.author.affiliationUniversity of the Philippines Los Banos
oairecerif.author.affiliationLondon School of Hygiene & Tropical Medicine
oairecerif.author.affiliationThe Nelson R. Mandela Medical School
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationAhmadu Bello University
oairecerif.author.affiliationUniversity of Ilorin
oairecerif.author.affiliationUniversity of Lagos
oairecerif.author.affiliationHigh Institute of Public Health
oairecerif.author.affiliationGlobal Health Focus

Files

Collections